Vimentin restrains regulatory T-cell suppression of graft-versus-host disease
Regulatory T-cells (Treg) are critical for maintaining immune homeostasis. However, current Treg immunotherapies do not optimally treat inflammatory diseases in patients. Understanding the cellular processes that control Treg function may allow for the augmentation of therapeutic efficacy. In contra...
Main Authors: | McDonal-Hyman, C, Muller, J, Loschi, M, Thangavelu, G, Saha, A, Kumari, S, Reichenbach, D, Smith, M, Zhang, G, Koehn, BH, Lin, J, Mitchell, JS, Fife, BT, Panoskaltsis-Mortari, A, Feser, C, Kirchmeier, AK, Osborn, MJ, Hippen, KL, Kelekar, A, Serody, JS, Turka, LA, Munn, DH, Chi, H, Neubert, TA, Dustin, ML, Blazar, BR, Dustin, M |
---|---|
Format: | Journal article |
Published: |
American Society for Clinical Investigation
2018
|
Similar Items
-
Protein kinase C-theta and vimentin modulate multiple facets of regulatory T-cell function
by: McDonald-hyman, C, et al.
Published: (2016) -
Protein kinase C-theta interacts with mTORC2 and vimentin to limit regulatory T-cell function
by: McDonald-Hyman, C, et al.
Published: (2015) -
Effects of MicroRNA on Regulatory T Cells and Implications for Adoptive Cellular Therapy to Ameliorate Graft-versus-Host Disease
by: Keli L. Hippen, et al.
Published: (2018-01-01) -
Role of PD-1/PD-L1 in acute and chronic graft versus host disease
by: Blazar, B, et al.
Published: (2015) -
Loss of programmed death ligand-1 expression on donor T cells lessens acute graft-versus-host disease lethality
by: Saha, A, et al.
Published: (2015)